APO Research
Talk to an analyst

APO RESEARCH · REPORT

TYK2 Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global TYK2 Targeting Drugs Industry Growth and Trends Forecast to 2032

28 December 2025105 pages

Choose your research edition.

Industry ResearchTYK2 Targeting Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal TYK2 Targeting Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal TYK2 Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TYK2 Targeting Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal TYK2 Targeting Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global TYK2 Targeting Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TYK2 Targeting Drugs include Inventisbio, Qiyuan Biotechnology, InnoCare, Guangzhou Zaiji Pharmaceutical, Changzhou Hengbang Pharmaceutical, BeiGene, Ventyx Biosciences, Takeda (Nimbus Therapeutics) and Sareum Holdings Pic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global TYK2 Targeting Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The TYK2 Targeting Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global TYK2 Targeting Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to TYK2 Targeting Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global TYK2 Targeting Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

TYK2 Targeting Drugs Market by Company

Inventisbio

Qiyuan Biotechnology

InnoCare

Guangzhou Zaiji Pharmaceutical

Changzhou Hengbang Pharmaceutical

BeiGene

Ventyx Biosciences

Takeda (Nimbus Therapeutics)

Sareum Holdings Pic

Oncostellae

Galapagos NV

Bristol Myers Squibb

TYK2 Targeting Drugs Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

TYK2 Targeting Drugs Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

TYK2 Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TYK2 Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TYK2 Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TYK2 Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of TYK2 Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single-target Inhibitors Table 2. Major Company of Dual-target Inhibitors Table 3. Global TYK2 Targeting Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global TYK2 Targeting Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global TYK2 Targeting Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global TYK2 Targeting Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global TYK2 Targeting Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global TYK2 Targeting Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global TYK2 Targeting Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global TYK2 Targeting Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa TYK2 Targeting Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. TYK2 Targeting Drugs Industry Trends Table 25. TYK2 Targeting Drugs Industry Drivers Table 26. TYK2 Targeting Drugs Industry Opportunities and Challenges Table 27. TYK2 Targeting Drugs Industry Restraints Table 28. Global TYK2 Targeting Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global TYK2 Targeting Drugs Revenue Market Share by Company (2021-2026) Table 30. Global TYK2 Targeting Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global TYK2 Targeting Drugs Sales Share by Company (2021-2026) Table 32. Global TYK2 Targeting Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global TYK2 Targeting Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global TYK2 Targeting Drugs Major Company Production Sites and Headquarters Table 35. Global TYK2 Targeting Drugs Company, Product Type & Application Table 36. Global TYK2 Targeting Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global TYK2 Targeting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global TYK2 Targeting Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global TYK2 Targeting Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global TYK2 Targeting Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global TYK2 Targeting Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global TYK2 Targeting Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global TYK2 Targeting Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global TYK2 Targeting Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global TYK2 Targeting Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global TYK2 Targeting Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global TYK2 Targeting Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global TYK2 Targeting Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global TYK2 Targeting Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global TYK2 Targeting Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global TYK2 Targeting Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global TYK2 Targeting Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global TYK2 Targeting Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global TYK2 Targeting Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global TYK2 Targeting Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa TYK2 Targeting Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Inventisbio Company Information Table 72. Inventisbio Business Overview Table 73. Inventisbio TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Inventisbio TYK2 Targeting Drugs Product Portfolio Table 75. Inventisbio Recent Development Table 76. Qiyuan Biotechnology Company Information Table 77. Qiyuan Biotechnology Business Overview Table 78. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio Table 80. Qiyuan Biotechnology Recent Development Table 81. InnoCare Company Information Table 82. InnoCare Business Overview Table 83. InnoCare TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. InnoCare TYK2 Targeting Drugs Product Portfolio Table 85. InnoCare Recent Development Table 86. Guangzhou Zaiji Pharmaceutical Company Information Table 87. Guangzhou Zaiji Pharmaceutical Business Overview Table 88. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 90. Guangzhou Zaiji Pharmaceutical Recent Development Table 91. Changzhou Hengbang Pharmaceutical Company Information Table 92. Changzhou Hengbang Pharmaceutical Business Overview Table 93. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 95. Changzhou Hengbang Pharmaceutical Recent Development Table 96. BeiGene Company Information Table 97. BeiGene Business Overview Table 98. BeiGene TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. BeiGene TYK2 Targeting Drugs Product Portfolio Table 100. BeiGene Recent Development Table 101. Ventyx Biosciences Company Information Table 102. Ventyx Biosciences Business Overview Table 103. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio Table 105. Ventyx Biosciences Recent Development Table 106. Takeda (Nimbus Therapeutics) Company Information Table 107. Takeda (Nimbus Therapeutics) Business Overview Table 108. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio Table 110. Takeda (Nimbus Therapeutics) Recent Development Table 111. Sareum Holdings Pic Company Information Table 112. Sareum Holdings Pic Business Overview Table 113. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio Table 115. Sareum Holdings Pic Recent Development Table 116. Oncostellae Company Information Table 117. Oncostellae Business Overview Table 118. Oncostellae TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Oncostellae TYK2 Targeting Drugs Product Portfolio Table 120. Oncostellae Recent Development Table 121. Galapagos NV Company Information Table 122. Galapagos NV Business Overview Table 123. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Galapagos NV TYK2 Targeting Drugs Product Portfolio Table 125. Galapagos NV Recent Development Table 126. Bristol Myers Squibb Company Information Table 127. Bristol Myers Squibb Business Overview Table 128. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio Table 130. Bristol Myers Squibb Recent Development Table 131. North America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 133. North America TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 134. North America TYK2 Targeting Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America TYK2 Targeting Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. North America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America TYK2 Targeting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. North America TYK2 Targeting Drugs Market Share by Country (2021-2026) Table 139. North America TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America TYK2 Targeting Drugs Market Share Forecast by Country (2027-2032) Table 141. Europe TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 143. Europe TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 144. Europe TYK2 Targeting Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe TYK2 Targeting Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Europe TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe TYK2 Targeting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe TYK2 Targeting Drugs Market Share by Country (2021-2026) Table 149. Europe TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe TYK2 Targeting Drugs Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific TYK2 Targeting Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific TYK2 Targeting Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific TYK2 Targeting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific TYK2 Targeting Drugs Market Share by Country (2021-2026) Table 159. Asia-Pacific TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific TYK2 Targeting Drugs Market Share Forecast by Country (2027-2032) Table 161. Latin America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 163. Latin America TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 164. Latin America TYK2 Targeting Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America TYK2 Targeting Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America TYK2 Targeting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America TYK2 Targeting Drugs Market Share by Country (2021-2026) Table 169. Latin America TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America TYK2 Targeting Drugs Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa TYK2 Targeting Drugs Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa TYK2 Targeting Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa TYK2 Targeting Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa TYK2 Targeting Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa TYK2 Targeting Drugs Market Share by Country (2021-2026) Table 179. Middle East and Africa TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa TYK2 Targeting Drugs Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. TYK2 Targeting Drugs Distributors List Table 184. TYK2 Targeting Drugs Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. TYK2 Targeting Drugs Image Figure 2. Global TYK2 Targeting Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TYK2 Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global TYK2 Targeting Drugs Sales (2021-2032) & (K Units) Figure 5. Single-target Inhibitors Image Figure 6. Global Single-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dual-target Inhibitors Image Figure 8. Global Dual-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global TYK2 Targeting Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global TYK2 Targeting Drugs Market Share by Type 2025 VS 2032 Figure 11. North America TYK2 Targeting Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America TYK2 Targeting Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe TYK2 Targeting Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe TYK2 Targeting Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific TYK2 Targeting Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific TYK2 Targeting Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America TYK2 Targeting Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America TYK2 Targeting Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa TYK2 Targeting Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa TYK2 Targeting Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 TYK2 Targeting Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Psoriasis Image Figure 24. Global Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Systemic Lupus Erythematosus Image Figure 26. Global Systemic Lupus Erythematosus Sales YoY Growth (2021-2032) & (K Units) Figure 27. Dermatitis Image Figure 28. Global Dermatitis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Arthritis Image Figure 30. Global Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global TYK2 Targeting Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global TYK2 Targeting Drugs Market Share by Application 2025 VS 2032 Figure 35. North America TYK2 Targeting Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America TYK2 Targeting Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe TYK2 Targeting Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe TYK2 Targeting Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific TYK2 Targeting Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific TYK2 Targeting Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America TYK2 Targeting Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America TYK2 Targeting Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa TYK2 Targeting Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa TYK2 Targeting Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America TYK2 Targeting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America TYK2 Targeting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe TYK2 Targeting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe TYK2 Targeting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific TYK2 Targeting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific TYK2 Targeting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America TYK2 Targeting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America TYK2 Targeting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa TYK2 Targeting Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa TYK2 Targeting Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa TYK2 Targeting Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. TYK2 Targeting Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. TYK2 Targeting Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Inventisbio
  • Qiyuan Biotechnology
  • InnoCare
  • Guangzhou Zaiji Pharmaceutical
  • Changzhou Hengbang Pharmaceutical
  • BeiGene
  • Ventyx Biosciences
  • Takeda (Nimbus Therapeutics)
  • Sareum Holdings Pic
  • Oncostellae
  • Galapagos NV
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TYK2 Targeting Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global TYK2 Targeting Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 TYK2 Targeting Drugs Market by Type
  6. 1.3.1 Single-target Inhibitors
  7. 1.3.2 Dual-target Inhibitors
  8. 1.4 Global TYK2 Targeting Drugs Market Size by Type
  9. 1.4.1 Global TYK2 Targeting Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global TYK2 Targeting Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global TYK2 Targeting Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 TYK2 Targeting Drugs Industry Trends
  2. 2.2 TYK2 Targeting Drugs Industry Drivers
  3. 2.3 TYK2 Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 TYK2 Targeting Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by TYK2 Targeting Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by TYK2 Targeting Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by TYK2 Targeting Drugs Price (2021-2026)
  4. 3.4 Global TYK2 Targeting Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TYK2 Targeting Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global TYK2 Targeting Drugs Company, Product Type & Application
  7. 3.7 Global TYK2 Targeting Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TYK2 Targeting Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TYK2 Targeting Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TYK2 Targeting Drugs Tier 1, Tier 2, and Tier 3
4 TYK2 Targeting Drugs Regional Status and Outlook
  1. 4.1 Global TYK2 Targeting Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global TYK2 Targeting Drugs Historic Market Size by Region
  3. 4.2.1 Global TYK2 Targeting Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global TYK2 Targeting Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global TYK2 Targeting Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global TYK2 Targeting Drugs Forecasted Market Size by Region
  7. 4.3.1 Global TYK2 Targeting Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global TYK2 Targeting Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global TYK2 Targeting Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 TYK2 Targeting Drugs by Application
  1. 5.1 TYK2 Targeting Drugs Market by Application
  2. 5.1.1 Psoriasis
  3. 5.1.2 Systemic Lupus Erythematosus
  4. 5.1.3 Dermatitis
  5. 5.1.4 Arthritis
  6. 5.1.5 Others
  7. 5.2 Global TYK2 Targeting Drugs Market Size by Application
  8. 5.2.1 Global TYK2 Targeting Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global TYK2 Targeting Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global TYK2 Targeting Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Inventisbio
  2. 6.1.1 Inventisbio Company Information
  3. 6.1.2 Inventisbio Business Overview
  4. 6.1.3 Inventisbio TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
  6. 6.1.5 Inventisbio Recent Developments
  7. 6.2 Qiyuan Biotechnology
  8. 6.2.1 Qiyuan Biotechnology Company Information
  9. 6.2.2 Qiyuan Biotechnology Business Overview
  10. 6.2.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
  12. 6.2.5 Qiyuan Biotechnology Recent Developments
  13. 6.3 InnoCare
  14. 6.3.1 InnoCare Company Information
  15. 6.3.2 InnoCare Business Overview
  16. 6.3.3 InnoCare TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 InnoCare TYK2 Targeting Drugs Product Portfolio
  18. 6.3.5 InnoCare Recent Developments
  19. 6.4 Guangzhou Zaiji Pharmaceutical
  20. 6.4.1 Guangzhou Zaiji Pharmaceutical Company Information
  21. 6.4.2 Guangzhou Zaiji Pharmaceutical Business Overview
  22. 6.4.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  24. 6.4.5 Guangzhou Zaiji Pharmaceutical Recent Developments
  25. 6.5 Changzhou Hengbang Pharmaceutical
  26. 6.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 6.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 6.5.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  30. 6.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 6.6 BeiGene
  32. 6.6.1 BeiGene Company Information
  33. 6.6.2 BeiGene Business Overview
  34. 6.6.3 BeiGene TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BeiGene TYK2 Targeting Drugs Product Portfolio
  36. 6.6.5 BeiGene Recent Developments
  37. 6.7 Ventyx Biosciences
  38. 6.7.1 Ventyx Biosciences Company Information
  39. 6.7.2 Ventyx Biosciences Business Overview
  40. 6.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
  42. 6.7.5 Ventyx Biosciences Recent Developments
  43. 6.8 Takeda (Nimbus Therapeutics)
  44. 6.8.1 Takeda (Nimbus Therapeutics) Company Information
  45. 6.8.2 Takeda (Nimbus Therapeutics) Business Overview
  46. 6.8.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
  48. 6.8.5 Takeda (Nimbus Therapeutics) Recent Developments
  49. 6.9 Sareum Holdings Pic
  50. 6.9.1 Sareum Holdings Pic Company Information
  51. 6.9.2 Sareum Holdings Pic Business Overview
  52. 6.9.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
  54. 6.9.5 Sareum Holdings Pic Recent Developments
  55. 6.10 Oncostellae
  56. 6.10.1 Oncostellae Company Information
  57. 6.10.2 Oncostellae Business Overview
  58. 6.10.3 Oncostellae TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
  60. 6.10.5 Oncostellae Recent Developments
  61. 6.11 Galapagos NV
  62. 6.11.1 Galapagos NV Company Information
  63. 6.11.2 Galapagos NV Business Overview
  64. 6.11.3 Galapagos NV TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
  66. 6.11.5 Galapagos NV Recent Developments
  67. 6.12 Bristol Myers Squibb
  68. 6.12.1 Bristol Myers Squibb Company Information
  69. 6.12.2 Bristol Myers Squibb Business Overview
  70. 6.12.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
  72. 6.12.5 Bristol Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America TYK2 Targeting Drugs Sales by Country
  2. 7.1.1 North America TYK2 Targeting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America TYK2 Targeting Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America TYK2 Targeting Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America TYK2 Targeting Drugs Market Size by Country
  6. 7.2.1 North America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America TYK2 Targeting Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe TYK2 Targeting Drugs Sales by Country
  2. 8.1.1 Europe TYK2 Targeting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe TYK2 Targeting Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe TYK2 Targeting Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe TYK2 Targeting Drugs Market Size by Country
  6. 8.2.1 Europe TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe TYK2 Targeting Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific TYK2 Targeting Drugs Sales by Country
  2. 9.1.1 Asia-Pacific TYK2 Targeting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific TYK2 Targeting Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific TYK2 Targeting Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific TYK2 Targeting Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific TYK2 Targeting Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America TYK2 Targeting Drugs Sales by Country
  2. 10.1.1 South America TYK2 Targeting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America TYK2 Targeting Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America TYK2 Targeting Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America TYK2 Targeting Drugs Market Size by Country
  6. 10.2.1 South America TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America TYK2 Targeting Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa TYK2 Targeting Drugs Sales by Country
  2. 11.1.1 Middle East and Africa TYK2 Targeting Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa TYK2 Targeting Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa TYK2 Targeting Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa TYK2 Targeting Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa TYK2 Targeting Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa TYK2 Targeting Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa TYK2 Targeting Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 TYK2 Targeting Drugs Value Chain Analysis
  2. 12.1.1 TYK2 Targeting Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 TYK2 Targeting Drugs Production Mode & Process
  7. 12.2 TYK2 Targeting Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 TYK2 Targeting Drugs Distributors
  10. 12.2.3 TYK2 Targeting Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst